Workflow
疑难眼病诊疗
icon
Search documents
又一家外商独资三级专科医院,来了!
Xin Lang Cai Jing· 2026-02-04 12:20
Core Viewpoint - The establishment of Jiangsu TaiXue Eye Hospital in Suzhou represents a significant step in the expansion of foreign investment in the healthcare sector, addressing the demand for high-level ophthalmic medical services in the region [1][3]. Group 1: Project Overview - The first phase of the Jiangsu TaiXue Eye Hospital will cover approximately 3,200 square meters and is scheduled to commence construction in the first half of this year [1][3]. - The hospital will focus on the diagnosis and treatment of complex eye diseases, technology transfer, and international medical services, thereby enhancing the local healthcare capabilities [1][3]. Group 2: Policy Context - The project is part of a broader initiative to open up the healthcare sector, following the announcement by the Ministry of Commerce and other agencies in September 2024, which allows the establishment of wholly foreign-owned hospitals in Suzhou and eight other cities [3][7]. - In April 2025, the State Council approved a plan to accelerate the opening of the service industry, including Suzhou in the pilot program [3][7]. Group 3: Company Background - TaiXue Eye Hospital Group originates from the Taiwan University Eye Care Group, established in 1992 and listed in 2004, becoming a leading ophthalmic chain in Taiwan with 20 eye centers and 60 optical centers [4][8]. - The group began its expansion into mainland China in 2014 through the acquisition of Ningbo Ming Shikang Eye Clinic and established its mainland headquarters in Hangzhou in 2017 [4][9]. Group 4: Expansion Strategy - In mainland China, TaiXue Eye Hospital primarily employs a model of building outpatient departments and collaborating with public and private hospitals to establish eye care centers [5][9]. - As of early 2026, the group has opened nine eye centers/hospitals in regions including Hangzhou, Ningbo, Jiangsu, and Shanghai, and has formed strategic partnerships with multiple hospitals [5][9].